A "vaccine" which harnesses the body’s own immune system to fight prostate cancer has been approved for use by US drug regulators. Provenge – which is designed to be used in men with advanced disease – is the first of its kind to be accepted by the Food and Drug...

Men living in deprived areas are less likely to receive radiotherapy or surgery for prostate cancer than their richer counterparts, a study suggests. Writing in the British Medical Journal, researchers who studied 35,000 men described "substantial" differences between what rich and...

Men should be warned that testing for prostate cancer can lead to unnecessary distress, researchers urge. While the test is not routinely offered in the UK, men over 45 may request one. If a man has high levels of the protein prostate specific antigen, a biopsy is carried out, which in most...

A drug already used in men with enlarged prostates seems to cut the risk of prostate cancer developing, a large international study has shown. A four-year trial in more than 6,500 men found those who took dutasteride had a 23% lower risk of prostate cancer than those who took a dummy pill....

By Helen BriggsHealth reporter, BBC News Infertile men may have a higher risk of developing prostate cancer, US data suggests. Researchers looked at the cancer records of men attending infertility clinics in California. They found men unable to father a child were nearly three times more...